Cover Image

Exploration of Clinical Breakpoint of Danofloxacin for <i>Glaesserella parasuis</i> in Plasma and in PELF

<b>Background:</b> In order to establish the clinical breakpoint (CBP) of danofloxacin against <i>G. parasuis</i>, three cutoff values, including epidemiological cutoff value (ECV), pharmacokinetic-pharmacodynamic (PK-PD) cutoff value (CO<sub>PD</sub>) and clinica...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zihui Xu (Author), Anxiong Huang (Author), Xun Luo (Author), Peng Zhang (Author), Lingli Huang (Author), Xu Wang (Author), Kun Mi (Author), Shiwei Fang (Author), Xiao Huang (Author), Jun Li (Author), Zonghui Yuan (Author), Haihong Hao (Author)
Format:	Book
Published:	MDPI AG, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dosing Regimen of Aditoprim and Sulfamethoxazole Combination for the <i>Glaesserella parasuis</i> Containing Resistance and Virulence Genes
by: Anxiong Huang, et al.
Published: (2022)

Rational Use of Danofloxacin for Treatment of <i>Mycoplasma gallisepticum</i> in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift
by: Shuge Wang, et al.
Published: (2022)

Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study
by: Anxiong Huang, et al.
Published: (2022)

Pigs Overexpressing Porcine β-Defensin 2 Display Increased Resilience to <i>Glaesserella parasuis</i> Infection
by: Jing Huang, et al.
Published: (2020)

Virulence and Antimicrobial Resistance Characterization of <i>Glaesserella parasuis</i> Isolates Recovered from Spanish Swine Farms
by: Alba González-Fernández, et al.
Published: (2024)

Determination of Susceptibility Breakpoint for Cefquinome against <i>Streptococcus suis</i> in Pigs
by: Kun Mi, et al.
Published: (2021)

Glaesserella parasuis: serotipos y virulencia de cepas aisladas de cerdos en Itapúa-Paraguay entre febrero del 2022 a marzo del 2023
by: Nadia Denisse Zaracho Paniagua, et al.
Published: (2023)

PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against <i>Streptococcus suis</i> in Piglets
by: Anxiong Huang, et al.
Published: (2022)

Effect of Danofloxacin Treatment on the Development of Fluoroquinolone Resistance in <i>Campylobacter jejuni</i> in Calves
by: Debora Brito Goulart, et al.
Published: (2022)

Fe de erratas de "Glaesserella parasuis: serotipos y virulencia de cepas aisladas de cerdos en Itapúa-Paraguay entre febrero del 2022 a marzo del 2023"
by: Nadia Denisse Zaracho Paniagua, et al.
Published: (2023)

Co-Existence of Oxazolidinone Resistance Genes <i>cfr</i>(D) and <i>optrA</i> on Two <i>Streptococcus parasuis</i> Isolates from Swine
by: Ning Han, et al.
Published: (2023)

Preparation of Aditoprim Injection against <i>Streptococcus suis</i> in Pigs and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling
by: Wei Qu, et al.
Published: (2022)

Mechanisms of the Testis Toxicity Induced by Chronic Exposure to Mequindox
by: Qianying Liu, et al.
Published: (2017)

In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration
by: Xia Xiao, et al.
Published: (2018)

Development and Validation of A Spectrofluorimetric Determination of Calf Thymus DNA Using a Terbium-Danofloxacin Probe
by: Naser Soltani, et al.
Published: (2016)

VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
by: Min-Hye Kim, et al.
Published: (2021)

Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
by: Everson Willian Fialho Cordeiro, et al.
Published: (2020)

OGM and WES identifies translocation breakpoints in PKD1 gene in an polycystic kidney patient and healthy baby delivered using PGT
by: Peiwen Xu, et al.
Published: (2023)

Pharmacokinetic Behavior and Pharmacokinetic/Pharmacodynamic Integration of Danofloxacin Following Single or Co-Administration with Meloxicam in Healthy Lambs and Lambs with Respiratory Infections
by: Mehmet Nihat Ural, et al.
Published: (2021)

Implementation of a Breakpoint Halfway Discretization to Predict Jakarta's Air Quality
by: Winoto Chandra, et al.
Published: (2022)

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
by: Kristian Ängeby, et al.

Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes
by: Matthaios Papadimitriou-Olivgeris, et al.
Published: (2020)

Enhanced Treatment Effects of Tilmicosin Against <i>Staphylococcus aureus</i> Cow Mastitis by Self-Assembly Sodium Alginate-Chitosan Nanogel
by: Kaixiang Zhou, et al.
Published: (2019)

Changing times: The impact of gram-negative breakpoint changes over the previous decade
by: Wes M. Johnson, et al.
Published: (2022)

Diabetes care cascade in Ukraine: an analysis of breakpoints and opportunities for improved diabetes outcomes
by: Robyn Margaret Stuart, et al.
Published: (2020)

Effects of Edible Grass (<i>Rumex patientia</i> L. × <i>Rumex tianschanicus</i> A. LOS) Leaf Powder on Growth Performance, Antioxidant Properties, Cecal Short-Chain Fatty Acids, and Microbial Community Levels in Broilers
by: Xinyao Li, et al.
Published: (2024)

Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview
by: Lulu Huang, et al.
Published: (2022)

Impact of MIC Breakpoint Changes for Enterobacterales on Trends of Antibiotic Susceptibilities in An Academic Medical Center
by: David Evans, et al.
Published: (2024)

RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. <i>Pharmaceutics</i> 2021, <i>13</i>, 330
by: Shiwei Zhou, et al.
Published: (2023)

Plasma-Activated Saline Promotes Antibiotic Treatment of Systemic Methicillin-Resistant <i>Staphylococcus aureus</i> Infection
by: Lu Yang, et al.
Published: (2021)

Combining the In Silico and In Vitro Assays to Identify <i>Strobilanthes cusia</i> Kuntze Bioactives against Penicillin-Resistant <i>Streptococcus pneumoniae</i>
by: Xiaoyu Han, et al.
Published: (2023)

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by <em>Enterobacteriaceae</em>
by: Ga Eun Park, et al.
Published: (2021)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
by: Stephanie C. Shealy, et al.
Published: (2020)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
by: Michele Massimino, et al.
Published: (2021)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
by: Petra Cagnardi, et al.
Published: (2018)

Breakpoint characterization of large deletions in <it>EXT1 </it>or <it>EXT2 </it>in 10 Multiple Osteochondromas families
by: Szuhai Karoly, et al.
Published: (2011)

Identifying inversions with breakpoints in the Dystrophin gene through long-read sequencing: report of two cases
by: Liqing Chen, et al.
Published: (2024)

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values
by: Marcia S. C. Melhem, et al.
Published: (2022)

Pharmacological Effects of <i>Houttuynia cordata</i> Thunb (<i>H. cordata</i>): A Comprehensive Review
by: Shahzad Rafiq, et al.
Published: (2022)

Uptake of Revised CLSI Breakpoints and Potential Impact among Hospitals Reporting to The NHSN AR Option, 2022
by: Allan Nkwata, et al.
Published: (2024)